0

N-Isobutyryl-L-cysteine

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP124529028
CAS124529-02-8
Structure
MDL NumberMFCD00155635
Molecular Weight191.25
InChI KeyBWBQXMAXLAHHTK-YFKPBYRVSA-N
Descriptionfor chiral derivatization, ≥97.0%
Assay≥97.0% (RT); ≥97.0%
Gradefor chiral derivatization
MP97-101 °C
Size250MG, 1G
Storage Conditions2-8°C
1

Chiral N-isobutyryl-cysteine Protected Gold Nanoparticles: Preparation, Size Selection, and Optical Activity in the UV-vis and Infrared

Cyrille Gautier, Thomas Bürgi

J Am Chem Soc. 2006 Aug 30;128(34):11079-87.

PMID: 16925425

1

Gold Nanoclusters for Parkinson's Disease Treatment

Guanbin Gao, Rui Chen, Meng He, Jing Li, Jing Li, Liyun Wang, Taolei Sun

Biomaterials. 2019 Feb;194:36-46.

PMID: 30576972

1

Inhibitory Effects of Cysteine and Cysteine Derivatives on Germination of Sporangiospores and Hyphal Growth of Different Zygomycetes

László Galgóczy, Laura Kovács, Krisztina Krizsán, Tamás Papp, Csaba Vágvölgyi

Mycopathologia. 2009 Sep;168(3):125-34.

PMID: 19381868

1

Liquid Chromatographic Determination of D- And L-amino Acids by Derivatization With O-Phthaldialdehyde and N-isobutyryl-L-cysteine. Applications With Reference to the Analysis of Peptidic Antibiotics, Toxins, Drugs and Pharmaceutically Used Amino Acids

H Brückner, T Westhauser, H Godel

J Chromatogr A. 1995 Sep 8;711(1):201-15.

PMID: 7496491

1

Synthesis of New N-isobutyryl-L-cysteine/MEA Conjugates: Evaluation of Their Free Radical-Scavenging Activities and anti-HIV Properties in Human Macrophages

Michael Smietana, Pascal Clayette, Patricia Mialocq, Jean-Jacques Vasseur, Joël Oiry

Bioorg Chem. 2008 Jun;36(3):133-40.

PMID: 18367231

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode